Hepatology Communications (Nov 2020)

ALT Levels for Asians With Metabolic Diseases: A Meta‐analysis of 86 Studies With Individual Patient Data Validation

  • Daniel Q. Huang,
  • Yee Hui Yeo,
  • Eunice Tan,
  • Hirokazu Takahashi,
  • Satoshi Yasuda,
  • Junji Saruwatari,
  • Kenichi Tanaka,
  • Kentaro Oniki,
  • Leslie Y. Kam,
  • Mark D. Muthiah,
  • Hideyuki Hyogo,
  • Masafumi Ono,
  • Scott D. Barnett,
  • Jie Li,
  • Biyao Zou,
  • James Fung,
  • Teng‐Yu Lee,
  • Vincent Wai‐Sun Wong,
  • Man‐Fung Yuen,
  • Yock Young Dan,
  • Seng Gee Lim,
  • Ramsey Cheung,
  • Hidenori Toyoda,
  • Yuichiro Eguchi,
  • Mindie H. Nguyen

DOI
https://doi.org/10.1002/hep4.1593
Journal volume & issue
Vol. 4, no. 11
pp. 1624 – 1636

Abstract

Read online

The current alanine aminotransferase (ALT) upper limit of normal was defined using selected healthy Caucasian blood donors. Given the global rise in obesity and different body habitus in Asians, we aimed to perform a systematic review and meta‐analysis combined with bootstrap modeling and individual patient data validation to estimate the ALT upper threshold for Asians, including the overweight and diabetics. We included studies from PubMed, Embase, and Cochrane database searches that identified individuals without known liver diseases (i.e., viral hepatitis, alcohol, and ultrasound‐detected nonalcoholic fatty liver disease). The mean ALT (U/L) was estimated using a random‐effects mixed model and upper threshold (95th‐percentile value, U/L) via a bootstrap model with 10,000 resamples. We screened 4,995 studies and identified 86 studies that reported ALT values for 526,641 individuals without excessive alcohol intake or known liver diseases, yielding a mean ALT of 19 and ALT upper threshold of 32. The ALT upper threshold was 37 in males versus 31 in females, 39 in overweight versus 28 in normal‐weight individuals, and 36 for diabetics versus 33 for nondiabetics. We validated our study level data with individual patient level data in 6,058 individuals from five study centers in Japan. Consistent with our study‐level data, we found that the ALT upper threshold in our individual patient data analysis was indeed higher in overweight versus normal‐weight individuals (39 vs. 32) and in diabetics versus nondiabetics (42 vs. 33). Conclusion: We provide validated reference ranges for ALT upper threshold derived from Asians without known liver disease, including individuals with ultrasound‐detected nonalcoholic fatty liver disease who are normal weight, overweight, nondiabetic, and diabetic, to inform practice.